Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy MediciNova (MNOV) stocks in Canada
Learn how to easily invest in MediciNova stocks.
MediciNova is a biotechnology business based in the US. MediciNova stocks (MNOV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.79 – a decrease of 11.9% over the previous week. MediciNova employs 9 staff and has a trailing 12-month revenue of around $4 million.
How to buy shares in MediciNova
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MNOV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in MediciNova?
- Has coronavirus impacted MediciNova shares?
- MediciNova shares summary
- Compare share dealing platforms
- Is MediciNova stock a buy or sell?
- MediciNova performance over time
- MediciNova's financials
- How volatile are MediciNova shares?
- Does MediciNova pay a dividend?
- Have MediciNova shares ever split?
- Other common questions
MediciNova stock price (NASDAQ:MNOV)Use our graph to track the performance of MNOV stocks over time.
MediciNova shares at a glance
|Latest market close||$2.22|
|52-week range||$2.40 - $10.81|
|50-day moving average||$3.06|
|200-day moving average||$3.75|
|Wall St. target price||$16.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.23|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy MediciNova stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
MediciNova price performance over time
|1 week (2022-01-14)||-11.90%|
|1 month (2021-12-23)||-20.43%|
|3 months (2021-10-22)||-39.34%|
|6 months (2021-07-23)||-40.48%|
|1 year (2021-01-22)||-62.75%|
|2 years (2020-01-24)||-65.01%|
|3 years (2019-01-24)||9.19|
|5 years (2017-01-24)||5.94|
|Revenue TTM||$4 million|
|Gross profit TTM||$0|
|Return on assets TTM||-8.23%|
|Return on equity TTM||-13.79%|
|Market capitalisation||$123.6 million|
TTM: trailing 12 months
MediciNova share dividends
We're not expecting MediciNova to pay a dividend over the next 12 months.
Have MediciNova's shares ever split?
MediciNova's shares were split on a 1:10 basis on 30 October 2006. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MediciNova shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for MediciNova shares which in turn could have impacted MediciNova's share price.
MediciNova share price volatility
Over the last 12 months, MediciNova's shares have ranged in value from as little as $2.4 up to $10.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MediciNova's is 1.2813. This would suggest that MediciNova's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MediciNova, Inc. , a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has a collaboration agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Stocks similar to MediciNova
MediciNova in the news
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
Earnings playbook: A complete guide to this week's reports, including the first of tech
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.